Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX: PBT) covers the month of December 2006. The document serves as a notice of the results of an Extraordinary General Meeting (EGM) held on December 28, 2006. Note: The metadata references "Alterity Therapeutics Ltd," but the filing text explicitly identifies the registrant as Prana Biotechnology Limited.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions regarding share issuance rather than financial performance.
Material Changes and Corporate Actions
The primary material event reported is the outcome of shareholder voting at the EGM. All resolutions were carried on a show of hands. The specific voting results were:
- Resolution 1 (Approval of Prior Issue of Securities): 40,547,820 votes For; 914,290 votes Against; 10,138,363 Abstentions.
- Resolution 2 (Approval of Issue of Securities): 36,589,693 votes For; 953,840 votes Against; 14,056,940 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the statutory reporting of the EGM results.
Investor Verification Checklist
- Verify the exact terms and pricing of the "Prior Issue of Securities" and the new "Issue of Securities" approved by shareholders.
- Confirm the total number of shares issued under these resolutions to assess potential dilution.
- Review the company's subsequent filings to determine if the approved capital raises were executed as planned.
- Clarify the relationship between the metadata name "Alterity Therapeutics Ltd" and the registrant "Prana Biotechnology Limited" to ensure correct entity tracking.